June 12, 2026 · Form 4 insider transaction
Haas Jason sold 3,000 shares of Ligand Pharmaceuticals Incorporated at $255.01 per share, a transaction worth $765.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $255.0000 to $255.2900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.